Company / Current Assets
Trevi Therapeutics, Inc. Current Assets History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$109.4M
FY2024
5-year range
$38.0M / $122.6M
FY2020-FY2024
Trend
+25.0%
vs FY2023
Sector context
#203 of 213
Health Care
What the data says
Among 213 Health Care companies, Trevi Therapeutics, Inc. is in the bottom 5% for current assets. Current Assets has fluctuated over the past 7 years, ranging from $9M in FY2018 to $123M in FY2022.
Based on SEC 10-K filings.
$109M in FY2024 with a 5-year CAGR of +12.9%.
Declined from $123M to $109M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +42.3%
- 5-Year CAGR
- +12.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 213This company $109.4M Sector average $2.5B
▼
-95.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +12.9%, indicating consistent growth.
- In FY2024, current assets increased 25.0% year-over-year.
- Ranks #203 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $109.4M | +25.0% |
| FY2023 | $87.5M | -28.6% |
| FY2022 | $122.6M | +223.0% |
| FY2021 | $38.0M | -18.0% |
| FY2020 | $46.3M | -22.3% |
| FY2019 | $59.6M | +574.9% |
| FY2018 | $8.8M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026